22 results
424B4
CGTX
Cognition Therapeutics Inc
14 Nov 22
Prospectus supplement with pricing info
6:02am
” and a “smaller reporting company” and, as a result of the reduced disclosure and governance requirements applicable to emerging growth companies … and regulations regarding corporate governance practices. The listing requirements of the Nasdaq Global Market and the rules of the SEC require that we
DRS
vdeoa
20 Oct 22
Draft registration statement
12:00am
DEF 14A
fwcptopuv
25 Apr 22
Definitive proxy
5:28pm
10-K
wcs4x
30 Mar 22
Annual report
7:40am
10-Q
6gclsjl03c2f
17 Nov 21
Quarterly report
5:15pm
8-K
c5mpcldcc5y9mp
3 Nov 21
Departure of Directors or Certain Officers
4:25pm
8-K
EX-3.2
l9c565ucrdc2y0
14 Oct 21
Amendments to Articles of Incorporation or Bylaws
4:41pm
424B4
ubngt3l3hg 1rrfmrqhg
12 Oct 21
Prospectus supplement with pricing info
4:11pm
S-1
1v2ec8
19 Jul 21
IPO registration
7:02am